_1777294007302_731105501.png&w=64&q=75){kind=small}
Russia approves a smallpox antiviral
Russia officially announced the registration of a local smallpox vaccine called "Nyoukh-14," which is used to treat infections caused by smallpox, monkeypox, and cowpox viruses. The drug was developed by the State Scientific Center of Virology and Biotechnology "Vector," in collaboration with the Novosibirsk Institute of Organic Chemistry and the Forugotsov Institute. It is considered effective against these viruses. This announcement comes at a time when Europe is moving toward imposing new sanctions on Russia, amid ongoing efforts to strengthen healthcare capabilities and address epidemic threats.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)